A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission Meeting Abstract

  

Authors:	O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; Wong, P.; Sabbatini, P.
Abstract Title:	A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
Meeting Title:	54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	15 Suppl.
Meeting Dates:	2018 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-05-20
Start Page:	307s
Language:	English
ACCESSION:	WOS:000442916002248
DOI:	10.1200/JCO.2018.36.15_suppl.5553
PROVIDER:	wos
Notes:	Meeting Abstract: 5553 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169563